<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04971993</url>
  </required_header>
  <id_info>
    <org_study_id>C2168</org_study_id>
    <nct_id>NCT04971993</nct_id>
  </id_info>
  <brief_title>Step and Walking Pattern From Cardiac Monitor Study</brief_title>
  <acronym>SWAN</acronym>
  <official_title>Step and Walking Pattern From Cardiac Monitor Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To understand the feasibility of characterizing walking patterns in heart failure subjects&#xD;
      and subjects at risk for arrhythmias using an investigational wearable monitor called the&#xD;
      SWAN study system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-randomized, feasibility study that will enroll up to 60 participants diagnosed&#xD;
      with Class II (30-35%) or III (30-35%) heart failure or are indicated for an insertable&#xD;
      cardiac monitor with no history of heart failure (30-35%).&#xD;
&#xD;
      There will be one study visit per participant and a follow up phone call. The study visit&#xD;
      includes device placement and data collection during rest and during a 6 minute hall walk.&#xD;
      The device will then be removed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Step Detection</measure>
    <time_frame>12 months</time_frame>
    <description>Characterize step count in class II and III heart failure and in ICM indicated patients with no history of heart failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walking Patterns</measure>
    <time_frame>12 months</time_frame>
    <description>Characterize walking patterns in class II and III heart failure and in ICM indicated patients with no history of heart failure.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure NYHA Class II</condition>
  <condition>Heart Failure NYHA Class III</condition>
  <condition>Insertable Cardiac Monitor</condition>
  <arm_group>
    <arm_group_label>Heart Failure NYHA Class II</arm_group_label>
    <description>Participants are diagnosed with NYHA Class II heart failure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure NYHA Class III</arm_group_label>
    <description>Participants are diagnosed with NYHA Class III heart failure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>At risk for arrythmias</arm_group_label>
    <description>Participants are indicated for an insertable cardiac monitor with no history of heart failure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wearable Cardiac Monitor</intervention_name>
    <description>Participants will be fitted with a wearable cardiac monitor placed on their skin that measures physiological signals.</description>
    <arm_group_label>At risk for arrythmias</arm_group_label>
    <arm_group_label>Heart Failure NYHA Class II</arm_group_label>
    <arm_group_label>Heart Failure NYHA Class III</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants are diagnosed with NYHA class II heart failure, class III heart failure or are&#xD;
        indicated for an ICM with no history of heart failure.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is 18 years or older&#xD;
&#xD;
          -  Willing and capable to provide written informed consent and agrees to participate in&#xD;
             all protocol required activities&#xD;
&#xD;
          -  Subjects must meet one of the following criteria:&#xD;
&#xD;
          -  Documented New York Heart Association (NYHA) class II or III heart failure within the&#xD;
             last 6 months&#xD;
&#xD;
        OR&#xD;
&#xD;
          -  Subjects that have a known heart condition (non-heart failure) and are at risk of&#xD;
             developing an abnormal heart rhythm, or have symptoms that may suggest a cardiac&#xD;
             arrhythmia such as dizziness, palpitations, syncope, chest pain and/or shortness of&#xD;
             breath&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not able to walk continuously for a period of 6 minutes&#xD;
&#xD;
          -  Prior hospitalization or surgery within previous 6 r weeks prior to consent.&#xD;
&#xD;
          -  Cardiovascular event such as unstable angina or myocardial infarction within previous&#xD;
             6 weeks prior to consent.&#xD;
&#xD;
          -  Subject is currently enrolled in another clinical trial (excluding registries) that&#xD;
             may interfere with the placement of the study system&#xD;
&#xD;
          -  Known allergy to materials used in the study (adhesive tape, titanium, ECG electrodes)&#xD;
&#xD;
          -  Subject is pregnant as indicated by subject report and/or medical record at the time&#xD;
             of enrollment&#xD;
&#xD;
          -  Subjects with rash or open wound on torso locations where investigational devices will&#xD;
             be placed&#xD;
&#xD;
          -  Have an active implantable device&#xD;
&#xD;
          -  Any past or current medical event that could represent a risk for the subject to&#xD;
             perform the study required activities in the opinion of the investigator&#xD;
&#xD;
          -  Any medical signs or symptoms that in the opinion of the investigator could represent&#xD;
             a risk for the subject (I.e. increased baseline blood pressure or heart rate).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Archana Rajdev, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CentraCare Heart and Vascular Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alan Bank, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United Heart and Vascular Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashley M Jensen, MS</last_name>
    <phone>651.582.4908</phone>
    <email>ashley.jensen@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pramodsingh Thakur, PhD</last_name>
    <phone>651.582.5863</phone>
    <email>pramodsingh.thakur@bsci.com</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 28, 2021</study_first_submitted>
  <study_first_submitted_qc>July 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>walk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

